Population
Patients with essential hypertension and normotensive individuals (narrative review)
Design
Review
Authors
Loading...
Insulin resistance screening may refine risk stratification in essential hypertension; leaves open whether targeted treatment modifies cardiovascular outcomes.
This review highlights that insulin resistance is a key pathophysiological factor in approximately half of patients with essential hypertension, significantly contributing to their cardiovascular risk.
Gerald M. Reaven (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: